RTW INVESTMENTS, LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001493215

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q2 2025 · 73 positions · Total reported value $7.02B · Top-10 concentration 50.0% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 37.2% · 10 new · 12 cut · 13 exited

Active Share (vs S&P 500): 99.8% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -7.3% · vs SPY -9.4% · Prev Value $11.71B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -1.7% · vs SPY -3.9% · Latest Value $9.91B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q2 2025 13F filing, RTW INVESTMENTS, LP disclosed 73 equity positions with a combined reported value of $7.02B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 50.0% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q2 2025 were MDGL ($603.37M), NTRA ($438.17M), PTCT ($378.33M). By sector, the heaviest allocations are Health Care 79.6%, Technology 0.4%. Versus the prior quarter, allocation shifted toward Other (+2.0pp) and away from Health Care (-2.0pp).

Versus the prior quarter, RTW INVESTMENTS, LP opened 10 new positions, trimmed 12 and fully exited 13, a turnover rate of 37.2% of positions. The portfolio's overlap with the prior quarter was 81% of names.

The largest new positions opened in Q2 2025 were NBIX ($133.49M), ABT ($60.39M), GH ($44.57M).

Of the 13 positions fully exited versus the prior quarter, the largest were GMED ($82.35M), ARVN ($23.41M), GKOS ($18.70M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2025)

  • NBIX NEUROCRINE BIOSCIENCES INC · $133.49M
  • ABT ABBOTT LABORATORIES · $60.39M
  • GH GUARDANT HEALTH INC · $44.57M
  • SLNO SOLENO THERAPEUTICS INC · $35.56M
  • MLTX MOONLAKE IMMUNOTHERAPEUTICS · $34.98M
  • JBIO JADE BIOSCIENCES INC · $14.48M
  • CRNX CRINETICS PHARMACEUTICALS IN · $13.43M
  • CTMX CYTOMX THERAPEUTICS INC. · $7.86M

Fully Exited (vs previous quarter)

  • GMED GLOBUS MED INC · prev qtr: $82.35M
  • ARVN ARVINAS INC · prev qtr: $23.41M
  • GKOS GLAUKOS CORP · prev qtr: $18.70M
  • BEAM BEAM THERAPEUTICS INC · prev qtr: $8.57M
  • BIOA BIOAGE LABS INC · prev qtr: $2.96M

Insider Transactions (Form 4)

Latest RTW INVESTMENTS, LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-11-09 Buy Orchestra BioMed Holdings, Inc. 1,200,000 $5.00 SEC filing
2026-07-21 J ALLURION TECHNOLOGIES, INC. 1,771 — SEC filing
2026-07-21 J ALLURION TECHNOLOGIES, INC. 19,934 — SEC filing
2026-07-21 J ALLURION TECHNOLOGIES, INC. 161,807 — SEC filing
2026-07-21 J ALLURION TECHNOLOGIES, INC. 209,254 — SEC filing
2026-04-27 Sell Orchestra BioMed Holdings, Inc. 32 $4.13 SEC filing
2026-04-27 Opt exercise Orchestra BioMed Holdings, Inc. 1,250,032 $0.00 SEC filing
2026-04-20 Buy Kailera Therapeutics, Inc. 500,000 $16.00 SEC filing

All insider transactions →

Fund Profile

RTW Investments, based in New York, NY, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 84 positions worth $11.71B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-78183 (status: Approved), registered 2013-06-13
  • Regulatory AUM (Form ADV): $14.14B as of 2026-03-30
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 3 private funds, of which 2 hedge funds
  • Website: rtwfunds.com

Portfolio Structure

  • 84 positions · $11.71B reported value (Q2 2026)
  • Top 10 holdings = 47.7% of reported value
  • Largest position: MDGL (MADRIGAL PHARMACEUTICALS INC) at 9.1%
  • Average position size: $139.44M

Sector Tilt

  • Health Care 99.1%
  • Industrials 0.4%
  • Information Technology 0.4%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 9 new, 24 added, 8 reduced, 13 exited
  • 43 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 79.6%
Technology 0.4%
Other 20.1%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 1.99M $603.37M 8.59%
8.59%
Hold
2 2.59M $438.17M 6.24%
6.24%
Hold
3 7.75M $378.33M 5.39%
5.39%
Add
4 673.50K $371.25M 5.29%
5.29%
Hold
5 5.76M $318.15M 4.53%
4.53%
Add
6 3.08M $310.43M 4.42%
4.42%
Add
7 5.48M $292.28M 4.16%
4.16%
Reduce
8 3.05M $288.65M 4.11%
4.11%
Add
9 9.62M $273.18M 3.89%
3.89%
Add
10 590.52K $233.63M 3.33%
3.33%
Hold
11 863.55K $221.61M 3.16%
3.16%
Hold
12 4.00M $210.43M 3.00%
3.00%
Reduce
13 9.00M $194.03M 2.76%
2.76%
Add
14 5.54M $193.62M 2.76%
2.76%
Add
15 1.52M $158.35M 2.25%
2.25%
Reduce
16 2.69M $153.11M 2.18%
2.18%
Add
17 4.87M $152.81M 2.18%
2.18%
Hold
18 4.68M $133.96M 1.91%
1.91%
Reduce
19 1.06M $133.49M 1.90%
1.90%
New
20 3.11M $126.05M 1.79%
1.79%
Reduce
21 2.71M $117.79M 1.68%
1.68%
Hold
22 683.29K $114.94M 1.64%
1.64%
Hold
23 2.58M $110.37M 1.57%
1.57%
Hold
24 202.46K $110.02M 1.57%
1.57%
Hold
25 2.72M $89.91M 1.28%
1.28%
Hold
26 500.00K $89.81M 1.28%
1.28%
Add
27 5.16M $71.91M 1.02%
1.02%
Add
28 5.54M $67.54M 0.96%
0.96%
Add
29 4.54M $62.25M 0.89%
0.89%
Add
30 1.71M $62.08M 0.88%
0.88%
Hold
31 444.00K $60.39M 0.86%
0.86%
New
32 5.12M $58.15M 0.83%
0.83%
Hold
33 25.02M $57.80M 0.82%
0.82%
Add
34 3.62M $54.22M 0.77%
0.77%
Hold
35 3.30M $48.04M 0.68%
0.68%
Hold
36 626.00K $46.37M 0.66%
0.66%
Add
37 856.50K $44.57M 0.64%
0.64%
New
38 1.70M $44.23M 0.63%
0.63%
Hold
39 17.69M $43.34M 0.62%
0.62%
Hold
40 6.97M $37.50M 0.53%
0.53%
Add
41 424.41K $35.56M 0.51%
0.51%
New
42 741.09K $34.98M 0.50%
0.50%
New
43 400.00K $25.42M 0.36%
0.36%
Hold
44 863.39K $25.31M 0.36%
0.36%
Hold
45 8.22M $23.02M 0.33%
0.33%
Add
46 8.31M $22.26M 0.32%
Form 4 · 1 →
0.32%
Add
47 1.95M $21.81M 0.31%
0.31%
Hold
48 1.36M $20.37M 0.29%
0.29%
Add
49 1.53M $20.10M 0.29%
0.29%
Add
50 1.97M $19.32M 0.28%
0.28%
Hold

FAQ

What did RTW INVESTMENTS, LP buy in 2025-Q2?

In its 2025-Q2 13F filing, RTW INVESTMENTS, LP reported 73 equity positions worth $7.02B in aggregate; its largest disclosed positions were MDGL ($603.37M), NTRA ($438.17M), PTCT ($378.33M).

How large is RTW INVESTMENTS, LP's portfolio?

RTW INVESTMENTS, LP reported $7.02B of long equity holdings across 73 positions as of 2025-Q2. Top-10 holdings account for 50.0% of reported value.

What is RTW INVESTMENTS, LP's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/rtw-investments/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →